Enhanced oncolytic potency of replicative adenovirus expressing p53

In Vivo Assessment of dbDNA GNEwt/bi-shRNA-GNEM743T Lipoplex for GNE Myopathy: Improved Potency and Safety.

The journal of gene medicine·2026

Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi.

Vaccine·2026

Preclinical assessment of GNEwt/bi-shRNA-GNEM743T lipoplex product development for GNE myopathy.

Future science OA·2026

Gemogenovatucel-T Advantage in Clonal Tumor Mutation Burden-High Ovarian Cancer.

JCO precision oncology·2026

Clinical characterization and therapeutic targeting of fusion genes in oncology.

Future oncology (London, England)·2025

Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product.

Scientific reports·2025

Extracellular matrix stiffness and mechanotransduction in cancer drug resistance.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026

Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026

Tumor-intrinsic PHGDH inhibition sensitizes colorectal cancer to PD-1 blockade via α-ketoglutarate-mediated macrophage reprogramming.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026

Consensus on standardized later-line systemic therapy for hepatocellular carcinoma.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026

OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026

ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026

Clonal evolution from primary to locally recurrent rectal cancer reveals recurrence-acquired potentially actionable alterations in treatment-naïve tumors.

Journal of gastroenterology·2026

Linking Early and Late Endpoints in Adjuvant Immunotherapy Trials: An Evaluation of Multiple Clinical Outcomes.

The oncologist·2026

Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-Derived external control arms.

Journal of the National Cancer Institute·2026

Trajectory Patterns of Perioperative Anxiety and Depressive Symptoms in Patients With Digestive System Malignancies and Their Impact on Postoperative Outcomes.

Actas espanolas de psiquiatria·2026

Extracellular vesicles and their translational therapeutic potential.

ADMET & DMPK·2026

Dynamic Procalcitonin Trajectories Predict Adverse Outcomes in Acute-on-Chronic Pancreatitis.

Cureus·2026

Related Experiment Videos

Enhanced oncolytic potency of replicative adenovirus expressing p53

Related Concept Videos

In Vivo Assessment of dbDNA GNEwt/bi-shRNA-GNEM743T Lipoplex for GNE Myopathy: Improved Potency and Safety.

Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi.

Preclinical assessment of GNEwt/bi-shRNA-GNEM743T lipoplex product development for GNE myopathy.

Gemogenovatucel-T Advantage in Clonal Tumor Mutation Burden-High Ovarian Cancer.

Clinical characterization and therapeutic targeting of fusion genes in oncology.

Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product.

Extracellular matrix stiffness and mechanotransduction in cancer drug resistance.

Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo.

Tumor-intrinsic PHGDH inhibition sensitizes colorectal cancer to PD-1 blockade via α-ketoglutarate-mediated macrophage reprogramming.

Consensus on standardized later-line systemic therapy for hepatocellular carcinoma.

OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression.

ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma.

Clonal evolution from primary to locally recurrent rectal cancer reveals recurrence-acquired potentially actionable alterations in treatment-naïve tumors.

Linking Early and Late Endpoints in Adjuvant Immunotherapy Trials: An Evaluation of Multiple Clinical Outcomes.

Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-Derived external control arms.

Trajectory Patterns of Perioperative Anxiety and Depressive Symptoms in Patients With Digestive System Malignancies and Their Impact on Postoperative Outcomes.

Extracellular vesicles and their translational therapeutic potential.

Dynamic Procalcitonin Trajectories Predict Adverse Outcomes in Acute-on-Chronic Pancreatitis.

Related Experiment Videos

Enhanced oncolytic potency of replicative adenovirus expressing p53

Related Concept Videos

Related Articles